Biomerieux

Biotechnology
BIM.PA
€ 96 (2.3)%
Share price
$ 12 bn
Market Cap
$ 12 bn
Enterprise Value

Carbon footprint

4.7 Ton
GHG emissions per $ 1 mln investment
0.13x the weighted average for S&P 500
FY2021
How is this calculated?
-1.7%
YOY change in GHG emissions
Weaker than the +4.2% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

-4.6%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -6.6% weighted average for S&P 500
FY2022
How is this calculated?

Biomerieux aims to reduce Scope 1 + 2 by 63% by 2034 from a base year 2019


1.5°C
Biomerieux's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Biomerieux's GHG emissions (location-based) (Kt of CO2e)
Biomerieux's Carbon intensity (Tons per 1 USDm)

Biomerieux's carbon footprint

Biomerieux reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 58 Kt (-1 /-1.7% y-o-y). Also positively, carbon intensity declined to 15 t (-1.7 /-10.5% y-o-y).

Biomerieux's Scope 3 emissions was up at 1,040 Kt (+45/+4.5% y-o-y). The growth has slowed compared to the trend since 4Q'17 (CAGR +35%).

The company is committed to reducing Scope 1 + 2 by 63% by 2034 from a base year 2019, which translates into the estimated reduction of -2.7 Kt per annum over the period of FY2022 - FY2034. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.

Company environmental metrics

Show more...